These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24489672)

  • 1. The association of cardioprotective medications with pneumonia-related outcomes.
    Wu A; Good C; Downs JR; Fine MJ; Pugh MJ; Anzueto A; Mortensen EM
    PLoS One; 2014; 9(1):e85797. PubMed ID: 24489672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes.
    Mortensen EM; Nakashima B; Cornell J; Copeland LA; Pugh MJ; Anzueto A; Good C; Restrepo MI; Downs JR; Frei CR; Fine MJ
    Clin Infect Dis; 2012 Dec; 55(11):1466-73. PubMed ID: 22918991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study.
    Franchi C; Rossio R; Mandelli S; Ardoino I; Nobili A; Peyvandi F; Mannucci PM;
    Intern Emerg Med; 2024 Apr; 19(3):689-696. PubMed ID: 38353881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of angiotensin-converting enzyme inhibitors and statins on the progression of aortic sclerosis and mortality.
    Ardehali R; Leeper NJ; Wilson AM; Heidenreich PA
    J Heart Valve Dis; 2012 May; 21(3):337-43. PubMed ID: 22808835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
    Korhonen MJ; Robinson JG; Annis IE; Hickson RP; Bell JS; Hartikainen J; Fang G
    J Am Coll Cardiol; 2017 Sep; 70(13):1543-1554. PubMed ID: 28935030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-Angiotensin System Blockers and Adverse Outcomes of Influenza and Pneumonia: A Danish Cohort Study.
    Christiansen CF; Heide-Jørgensen U; Rasmussen TB; Bodilsen J; Søgaard OS; Maeng M; Vistisen ST; Schmidt M; Pottegård A; Lund LC; Reilev M; Hallas J; Johansen NB; Brun NC; Sørensen HT; Thomsen RW
    J Am Heart Assoc; 2020 Oct; 9(19):e017297. PubMed ID: 32998607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications.
    Majd Z; Mohan A; Paranjpe R; Abughosh SM
    J Manag Care Spec Pharm; 2021 Feb; 27(2):186-197. PubMed ID: 33506725
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia.
    Mortensen EM; Pugh MJ; Copeland LA; Restrepo MI; Cornell JE; Anzueto A; Pugh JA
    Eur Respir J; 2008 Mar; 31(3):611-7. PubMed ID: 17959631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular medications used for comorbid diseases in patients with atrial fibrillation. The JoFib study.
    Alrabadi N; Al-Nusair M; Haddad R; Alburie L; Mhaidat N; Aljarrah M; Hamoudeh A
    Eur J Clin Pharmacol; 2024 Apr; 80(4):545-552. PubMed ID: 38253701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
    Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
    J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
    Li EC; Heran BS; Wright JM
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associastion of In-hospital Use of Statins, Aspirin, and Renin-Angiotensin-Aldosterone Inhibitors with Mortality and ICU Admission Due to COVID-19.
    Vahedian-Azimi A; Rahimibashar F; Najafi A; Kidde J; Shahriary A; Shojaei S; Pourhoseingholi MA; Jamialahmadi T; Sahebkar A
    Adv Exp Med Biol; 2021; 1327():205-214. PubMed ID: 34279841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Statins, Metformin, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin II Receptor Blockers on Age-Related Macular Degeneration.
    Lee H; Jeon HL; Park SJ; Shin JY
    Yonsei Med J; 2019 Jul; 60(7):679-686. PubMed ID: 31250582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials.
    Hoang V; Alam M; Addison D; Macedo F; Virani S; Birnbaum Y
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):189-98. PubMed ID: 26861251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease.
    Ho PM; Magid DJ; Masoudi FA; McClure DL; Rumsfeld JS
    BMC Cardiovasc Disord; 2006 Dec; 6():48. PubMed ID: 17173679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of medications to reduce cardiovascular risk among individuals with psychotic disorders and Type 2 diabetes.
    Kreyenbuhl J; Medoff DR; Seliger SL; Dixon LB
    Schizophr Res; 2008 Apr; 101(1-3):256-65. PubMed ID: 18353616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis.
    Caldeira D; Alarcão J; Vaz-Carneiro A; Costa J
    BMJ; 2012 Jul; 345():e4260. PubMed ID: 22786934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of statins and ACE inhibitors on mortality after COPD exacerbations.
    Mortensen EM; Copeland LA; Pugh MJ; Restrepo MI; de Molina RM; Nakashima B; Anzueto A
    Respir Res; 2009 Jun; 10(1):45. PubMed ID: 19493329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.